The Effect of Bortezomib on Expression of Inflammatory Cytokines and Survival in a Murine Sepsis Model Induced by Cecal Ligation and Puncture

논문상세정보
' The Effect of Bortezomib on Expression of Inflammatory Cytokines and Survival in a Murine Sepsis Model Induced by Cecal Ligation and Puncture' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • bortezomib
  • cecalligationandpuncture
  • inflammatory cytokines
  • lipopolysaccharide
  • proteasome inhibitor
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,744 0

0.0%

' The Effect of Bortezomib on Expression of Inflammatory Cytokines and Survival in a Murine Sepsis Model Induced by Cecal Ligation and Puncture' 의 참고문헌

  • Use of systemic proteasome inhibition as an immune-modulating agent in disease
    Mattingly LH Endocr Metab Immune Disord Drug Targets 7 : 29 ~ 34 [2007]
  • Use of systemic proteasome inhibition as an immune-modulating agent in disease
    Mattingly LH Endocr Metab Immune Disord Drug Targets 7 29-34 [2007]
  • Therapy of relapsed and refractory multiple myeloma
    Moehler T Recent Results Cancer Res 183 : 239 ~ 271 [2011]
  • Therapy of relapsed and refractory multiple myeloma
    Moehler T Recent Results Cancer Res 183 239-271 [2011]
  • Therapeutic potential of the proteasome inhibitor Bortezomib on titanium particle-induced inflammation in a murine model
    Mao X Inflammation 35 : 905 ~ 912 [2012]
  • Therapeutic potential of the proteasome inhibitor Bortezomib on titanium particle-induced inflammation in a murine model
    Mao X Inflammation 35 905-912 [2012]
  • The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B
    Palombella VJ Cell 78 : 773 ~ 785 [1994]
  • The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B
    Palombella VJ Cell 78 773-785 [1994]
  • The role of ubiquitin-proteasome pathway in oncogenic signaling
    Fuchs SY Cancer Biol Ther 1 : 337 ~ 341 [2002]
  • The role of ubiquitin-proteasome pathway in oncogenic signaling
    Fuchs SY Cancer Biol Ther 1 337-341 [2002]
  • The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats
    Yannaki E Arthritis Rheum 62 : 3277 ~ 3288 [2010]
  • The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats
    Yannaki E Arthritis Rheum 62 3277-3288 [2010]
  • The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events
    Qureshi N J Immunol 171 : 1515 ~ 1525 [2003]
  • The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events
    Qureshi N J Immunol 171 1515-1525 [2003]
  • The pathophysiology and treatment of sepsis
    Hotchkiss RS N Engl J Med 348 : 138 ~ 150 [2003]
  • The pathophysiology and treatment of sepsis
    Hotchkiss RS N Engl J Med 348 138-150 [2003]
  • The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model
    Jeong SJ Inflamm Res 61 : 1211 ~ 1218 [2012]
  • The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model
    Jeong SJ Inflamm Res 61 1211-1218 [2012]
  • The effect of proteasome inhibitor MG132 on experimental inflammatory bowel disease
    Inoue S Clin Exp Immunol 156 : 172 ~ 182 [2009]
  • The effect of proteasome inhibitor MG132 on experimental inflammatory bowel disease
    Inoue S Clin Exp Immunol 156 172-182 [2009]
  • The 26S proteasome system in the signaling pathways of TGF-beta superfamily
    Wang T Front Biosci 8 : d1109 ~ d1127 [2003]
  • The 26S proteasome system in the signaling pathways of TGF-beta superfamily
    Wang T Front Biosci 8 d1109-d1127 [2003]
  • Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
    Shaftel SS J Clin Invest 117 : 1595 ~ 1604 [2007]
  • Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
    Shaftel SS J Clin Invest 117 1595-1604 [2007]
  • Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB
    Fujioka S J Biol Chem 279 : 27549 ~ 27559 [2004]
  • Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB
    Fujioka S J Biol Chem 279 27549-27559 [2004]
  • Role of Toll-like receptors in the development of sepsis
    Tsujimoto H Shock 29 : 315 ~ 321 [2008]
  • Role of Toll-like receptors in the development of sepsis
    Tsujimoto H Shock 29 315-321 [2008]
  • Role and function of the 26S proteasome in proliferation and apoptosis
    Naujokat C Lab Invest 82 : 965 ~ 980 [2002]
  • Role and function of the 26S proteasome in proliferation and apoptosis
    Naujokat C Lab Invest 82 965-980 [2002]
  • Regulated ubiquitination of proteins in GPCR-initiated signaling pathways
    Wojcikiewicz RJ Trends Pharmacol Sci 25 : 35 ~ 41 [2004]
  • Regulated ubiquitination of proteins in GPCR-initiated signaling pathways
    Wojcikiewicz RJ Trends Pharmacol Sci 25 35-41 [2004]
  • Quantitation of messenger RNA by competitive RT-PCR: a simplified read out assay
    Colle JH J Immunol Methods 210 : 175 ~ 184 [1997]
  • Quantitation of messenger RNA by competitive RT-PCR: a simplified read out assay
    Colle JH J Immunol Methods 210 175-184 [1997]
  • Protein degradation and protection against misfoldor damaged proteins
    Goldberg AL. Nature 426 : 895 ~ 899 [2003]
  • Protein degradation and protection against misfoldor damaged proteins
    Goldberg AL. Nature 426 895-899 [2003]
  • Proteasome inhibitors: poisons and remedies
    Meiners S Med Res Rev 28 : 309 ~ 327 [2008]
  • Proteasome inhibitors: poisons and remedies
    Meiners S Med Res Rev 28 309-327 [2008]
  • Proteasome inhibition: a new anti-inflammatory strategy
    Elliott PJ J Mol Med (Berl) 81 : 235 ~ 245 [2003]
  • Proteasome inhibition: a new anti-inflammatory strategy
    Elliott PJ J Mol Med (Berl) 81 235-245 [2003]
  • Proteasome inhibition prevents development of experimental dermal fibrosis
    Koca SS Inflammation 35 : 810 ~ 817 [2012]
  • Proteasome inhibition prevents development of experimental dermal fibrosis
    Koca SS Inflammation 35 810-817 [2012]
  • Proteasome inhibition as a novel therapy in treating rheumatoid arthritis
    Brun J Med Hypotheses 71 : 65 ~ 72 [2008]
  • Proteasome inhibition as a novel therapy in treating rheumatoid arthritis
    Brun J Med Hypotheses 71 65-72 [2008]
  • Proteasome and peptidase function in MHC-class-I-mediated antigen presentation
    Kloetzel PM Curr Opin Immunol 16 : 76 ~ 81 [2004]
  • Proteasome and peptidase function in MHC-class-I-mediated antigen presentation
    Kloetzel PM Curr Opin Immunol 16 76-81 [2004]
  • Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice
    Fujitani Y J Immunol 168 : 443 ~ 449 [2002]
  • Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice
    Fujitani Y J Immunol 168 443-449 [2002]
  • Pathogenesis of renal failure in sepsis
    Thijs A Kidney Int Suppl 66 : S34 ~ S37 [1998]
  • Pathogenesis of renal failure in sepsis
    Thijs A Kidney Int Suppl 66 S34-S37 [1998]
  • Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells
    Meiners S Free Radic Biol Med 40 : 2232 ~ 2241 [2006]
  • Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells
    Meiners S Free Radic Biol Med 40 2232-2241 [2006]
  • Molecular Biology of the Cell
    Alberts B Garland Science [2002]
  • Molecular Biology of the Cell
    Alberts B - [2002]
  • Modulation of inflammatory response in sepsis by proteasome inhibition
    Safránek R Int J Exp Pathol 87 : 369 ~ 372 [2006]
  • Modulation of inflammatory response in sepsis by proteasome inhibition
    Safránek R Int J Exp Pathol 87 369-372 [2006]
  • Management of sepsis
    Russell JA N Engl J Med 355 : 1699 ~ 1713 [2006]
  • Management of sepsis
    Russell JA N Engl J Med 355 1699-1713 [2006]
  • Key inflammatory signaling pathways are regulated by the proteasome
    Shen J Shock 25 : 472 ~ 484 [2006]
  • Key inflammatory signaling pathways are regulated by the proteasome
    Shen J Shock 25 472-484 [2006]
  • Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection
    Lutterloh EC Crit Care 11 : R122 ~ [2007]
  • Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection
    Lutterloh EC Crit Care 11 R122- [2007]
  • Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse
    Hassan SW PLoS One : e8868 ~ [2010]
  • Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse
    Hassan SW PLoS One 5 e8868- [2010]
  • Immunomodulatory therapy for sepsis: an update
    Christaki E Expert Rev Anti Infect Ther 9 : 1013 ~ 1033 [2011]
  • Immunomodulatory therapy for sepsis: an update
    Christaki E Expert Rev Anti Infect Ther 9 1013-1033 [2011]
  • Immunodesign of experimental sepsis by cecal ligation and puncture
    Rittirsch D Nat Protoc 4 : 31 ~ 36 [2009]
  • Immunodesign of experimental sepsis by cecal ligation and puncture
    Rittirsch D Nat Protoc 4 31-36 [2009]
  • How the ubiquitin-proteasome system controls transcription
    Muratani M Nat Rev Mol Cell Biol 4 : 192 ~ 201 [2003]
  • How the ubiquitin-proteasome system controls transcription
    Muratani M Nat Rev Mol Cell Biol 4 192-201 [2003]
  • Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI
    Moore KW Science 248 : 1230 ~ 1234 [1990]
  • Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI
    Moore KW Science 248 1230-1234 [1990]
  • Homogeneous, bioluminescent proteasome assays
    O’Brien MA Methods Mol Biol 414 : 163 ~ 181 [2008]
  • Homogeneous, bioluminescent proteasome assays
    O’Brien MA Methods Mol Biol 414 163-181 [2008]
  • Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid beta-protein and chloroquine in cultured rat astrocytes
    Isobe I Neurosci Lett 266 : 129 ~ 132 [1999]
  • Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid beta-protein and chloroquine in cultured rat astrocytes
    Isobe I Neurosci Lett 266 129-132 [1999]
  • Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
    Sun K Blood 106 : 3293 ~ 3299 [2005]
  • Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
    Sun K Blood 106 3293-3299 [2005]
  • Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens
    Blanco B Leuk Res 35 : 1412 ~ 1415 [2011]
  • Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens
    Blanco B Leuk Res 35 1412-1415 [2011]
  • Degrade to create: developmental requirements for ubiquitin-mediated proteolysis during early C. elegans embryogenesis
    Bowerman B Development 133 : 773 ~ 784 [2006]
  • Degrade to create: developmental requirements for ubiquitin-mediated proteolysis during early C. elegans embryogenesis
    Bowerman B Development 133 773-784 [2006]
  • Deadly encounter: ubiquitin meets apoptosis
    Jesenberger V Nat Rev Mol Cell Biol 3 : 112 ~ 121 [2002]
  • Deadly encounter: ubiquitin meets apoptosis
    Jesenberger V Nat Rev Mol Cell Biol 3 112-121 [2002]
  • Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in Escherichia coli
    Kotewicz ML Gene 35 : 249 ~ 258 [1985]
  • Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in Escherichia coli
    Kotewicz ML Gene 35 249-258 [1985]
  • Cloning and expression of murine immune interferon cDNA
    Gray PW Proc Natl Acad Sci U S A 80 : 5842 ~ 5846 [1983]
  • Cloning and expression of murine immune interferon cDNA
    Gray PW Proc Natl Acad Sci U S A 80 5842-5846 [1983]
  • Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines
    Blanco B Blood 107 : 3575 ~ 3583 [2006]
  • Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines
    Blanco B Blood 107 3575-3583 [2006]
  • Bortezomib attenuates murine collagen-induced arthritis
    Lee SW Ann Rheum Dis 68 : 1761 ~ 1767 [2009]
  • Bortezomib attenuates murine collagen-induced arthritis
    Lee SW Ann Rheum Dis 68 1761-1767 [2009]
  • Bortezomib
    Paramore A Nat Rev Drug Discov 2 : 611 ~ 612 [2003]
  • Bortezomib
    Paramore A Nat Rev Drug Discov 2 611-612 [2003]
  • Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma
    Amiri KI Cancer Res 64 : 4912 ~ 4918 [2004]
  • Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma
    Amiri KI Cancer Res 64 4912-4918 [2004]
  • Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research
    Tsikas D J Chromatogr B Analyt Technol Biomed Life Sci 851 : 51 ~ 70 [2007]
  • Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research
    Tsikas D J Chromatogr B Analyt Technol Biomed Life Sci 851 51-70 [2007]
  • Altered MicroRNA expression in cervical carcinomas
    Lee JW Clin Cancer Res 14 : 2535 ~ 2542 [2008]
  • Altered MicroRNA expression in cervical carcinomas
    Lee JW Clin Cancer Res 14 2535-2542 [2008]
  • A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability
    Ishiyama M Talanta 44 : 1299 ~ 1305 [1997]
  • A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability
    Ishiyama M Talanta 44 1299-1305 [1997]
  • A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model
    Reis J Innate Immun 14 : 319 ~ 329 [2008]
  • A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model
    Reis J Innate Immun 14 319-329 [2008]